HydroxyChloroquine now made a H1 Drug in India; Exports banned

On March 27, 2020, the Ministry of Health and Family Welfare declared the Hydroxycholoroquine as a Schedule H1 drug. With this GOI has brough upon restrictions on sales and distribution of the drug.

Highlights

The Hydroxychloroquine drug was declared as an essential drug to treat COVID-19 patients. Out of the 4 treatments suggested by the World Health Organization to contain the virus, India adopted the use of Hydroxychloroquine. And hence, exports of the drugs were banned in the country. Currently the drug is being prescribed for symptomatic patients and also for asymptomatic patients that are in contact with the Corona infected patients.

What is Schedule H1?

The drugs listed under Schedule H1 are required to be sold under following conditions

  • The supply if H1 drugs are to be registered in a separate register. The register should hold the name and address of the prescriber and the patient. It should also hold quantity supplied. And these details are to be held by the supplier for a minimum of three years.
  • The drug listed under Schedule H1 should be labelled as “Rx” in red colour. The label should also carry precautionary warnings

Month: 

Category: 

Topics: 

Advertisement

Comments